Charles & Colvard Ltd Stock News

Charles & Colvard's lab grows precious stones known as moissanite. The majority of sales are online. It's trading at 71% of tangible book value which is mostly inventory and cash. It trades for $1.04

Charles & Colvard, Ltd. (CTHR) CEO Don O'Connell on Q1 2021 Results - Earnings Call Transcript

Silver Ring Value Partners recently released its Q3 2020 Investor Letter, a copy of which you can download here. The fund posted a return of 6.9% for the last 12 months (net), underperforming its benc

Why clients value avoiding losses more than winning gains.

Gateway Investment Advisers LLC lessened its holdings in shares of Charles River Laboratories Intl. Inc (NYSE:CRL) by 3.8% during the third quarter, according to the company in its most recent filing

Pacer Advisors Inc. bought a new stake in Charles River Laboratories Intl. Inc (NYSE:CRL) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exch

The

A fault at Australia’s only nuclear medical facility leads to shortages of isotope crucial for diagnosing a variety of conditions

Charles River Laboratories Intl. (NYSE:CRL) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a report issued on Thursday, Zacks.com reports. According to Z

Charles River Laboratories appoints George Llado, Senior Vice President and Chief Information Officer of Alexion Pharmaceuticals, to its Board

The

The